The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
People with disabilities in developing countries are at high risk of HIV infection with HIV prevalence nearly double that than among those without disabilities.
‘Surprising’ research from Conference on Retroviruses and Opportunistic Infections (CROI) shows drug resistance does not impact test-and-treat roll-out in South Africa – at least in the short term.
Drug trial results for new integrase inhibitor show promising viral suppression rates.
Mixed-status couples using PrEP could benefit from HIV self-testing as a way to quickly diagnose any new infections and reduce frequency of clinic visits.
Identifying individuals at high risk of disengaging with HIV care remains an important strategy for realising the benefits of antiretroviral treatment for public health.
Targeting the human genes that HIV takes over and uses to replicate could provide a new approach to HIV treatment and suppression – although more research is required.
HIV as a risk factor for diabetes has long been controversial, but new evidence shows that people living with HIV have increased diabetes prevalence compared to the general population.